nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.0706	0.0706	CcSEcCtD
Arformoterol—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.061	0.061	CcSEcCtD
Arformoterol—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.0406	0.0406	CcSEcCtD
Arformoterol—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.0376	0.0376	CcSEcCtD
Arformoterol—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0261	CcSEcCtD
Arformoterol—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0261	CcSEcCtD
Arformoterol—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0221	0.0221	CcSEcCtD
Arformoterol—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.0208	0.0208	CcSEcCtD
Arformoterol—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0193	CcSEcCtD
Arformoterol—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0187	CcSEcCtD
Arformoterol—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0187	CcSEcCtD
Arformoterol—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0181	0.0181	CcSEcCtD
Arformoterol—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0173	CcSEcCtD
Arformoterol—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0163	CcSEcCtD
Arformoterol—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0155	CcSEcCtD
Arformoterol—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0152	CcSEcCtD
Arformoterol—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0151	CcSEcCtD
Arformoterol—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Arformoterol—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0136	CcSEcCtD
Arformoterol—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0136	CcSEcCtD
Arformoterol—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Arformoterol—Gout—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0131	CcSEcCtD
Arformoterol—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Arformoterol—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0121	CcSEcCtD
Arformoterol—Melaena—Riluzole—amyotrophic lateral sclerosis	0.012	0.012	CcSEcCtD
Arformoterol—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Arformoterol—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Arformoterol—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Arformoterol—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00981	0.00981	CcSEcCtD
Arformoterol—Injury—Riluzole—amyotrophic lateral sclerosis	0.00967	0.00967	CcSEcCtD
Arformoterol—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00938	0.00938	CcSEcCtD
Arformoterol—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00915	0.00915	CcSEcCtD
Arformoterol—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00827	0.00827	CcSEcCtD
Arformoterol—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00809	0.00809	CcSEcCtD
Arformoterol—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Arformoterol—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00769	0.00769	CcSEcCtD
Arformoterol—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00769	0.00769	CcSEcCtD
Arformoterol—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00749	0.00749	CcSEcCtD
Arformoterol—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00739	0.00739	CcSEcCtD
Arformoterol—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00676	0.00676	CcSEcCtD
Arformoterol—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00672	CcSEcCtD
Arformoterol—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00666	CcSEcCtD
Arformoterol—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00653	CcSEcCtD
Arformoterol—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00643	0.00643	CcSEcCtD
Arformoterol—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00617	0.00617	CcSEcCtD
Arformoterol—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00611	0.00611	CcSEcCtD
Arformoterol—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00608	CcSEcCtD
Arformoterol—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00606	0.00606	CcSEcCtD
Arformoterol—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00605	CcSEcCtD
Arformoterol—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00603	0.00603	CcSEcCtD
Arformoterol—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00571	CcSEcCtD
Arformoterol—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00556	CcSEcCtD
Arformoterol—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00554	CcSEcCtD
Arformoterol—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0055	CcSEcCtD
Arformoterol—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00539	CcSEcCtD
Arformoterol—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00536	CcSEcCtD
Arformoterol—Tension—Riluzole—amyotrophic lateral sclerosis	0.00525	0.00525	CcSEcCtD
Arformoterol—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00524	CcSEcCtD
Arformoterol—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0052	CcSEcCtD
Arformoterol—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00518	CcSEcCtD
Arformoterol—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00515	CcSEcCtD
Arformoterol—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00502	CcSEcCtD
Arformoterol—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00497	CcSEcCtD
Arformoterol—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00492	CcSEcCtD
Arformoterol—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00489	CcSEcCtD
Arformoterol—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00483	CcSEcCtD
Arformoterol—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00473	CcSEcCtD
Arformoterol—Cough—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00467	CcSEcCtD
Arformoterol—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00462	CcSEcCtD
Arformoterol—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00456	CcSEcCtD
Arformoterol—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00456	CcSEcCtD
Arformoterol—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00456	CcSEcCtD
Arformoterol—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00454	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00453	CcSEcCtD
Arformoterol—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0045	0.0045	CcSEcCtD
Arformoterol—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00446	CcSEcCtD
Arformoterol—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00437	CcSEcCtD
Arformoterol—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00437	CcSEcCtD
Arformoterol—Infection—Riluzole—amyotrophic lateral sclerosis	0.00434	0.00434	CcSEcCtD
Arformoterol—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00429	CcSEcCtD
Arformoterol—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00427	CcSEcCtD
Arformoterol—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00425	CcSEcCtD
Arformoterol—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00398	CcSEcCtD
Arformoterol—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00395	CcSEcCtD
Arformoterol—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0039	CcSEcCtD
Arformoterol—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00389	CcSEcCtD
Arformoterol—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00385	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00377	CcSEcCtD
Arformoterol—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00377	CcSEcCtD
Arformoterol—Pain—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00374	CcSEcCtD
Arformoterol—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00374	CcSEcCtD
Arformoterol—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0036	CcSEcCtD
Arformoterol—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00357	CcSEcCtD
Arformoterol—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00347	CcSEcCtD
Arformoterol—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00345	CcSEcCtD
Arformoterol—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00345	CcSEcCtD
Arformoterol—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00322	CcSEcCtD
Arformoterol—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00314	CcSEcCtD
Arformoterol—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00309	CcSEcCtD
Arformoterol—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00299	CcSEcCtD
Arformoterol—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00289	CcSEcCtD
Arformoterol—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00278	CcSEcCtD
Arformoterol—Rash—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00276	CcSEcCtD
Arformoterol—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00275	CcSEcCtD
Arformoterol—Headache—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00274	CcSEcCtD
Arformoterol—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0026	CcSEcCtD
